ADMA vs. ^NIFTY500

Last updated Apr 2, 2026

Compare and contrast key facts about ADMA Biologics, Inc. (ADMA) and Nifty 500 (^NIFTY500).

Performance

ADMA vs. ^NIFTY500 - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Nifty 500 (^NIFTY500). The values are adjusted to include any dividend payments, if applicable.

ADMA vs. ^NIFTY500 - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ADMA ADMA Biologics, Inc.	-50.05%	6.36%	279.42%	16.49%	175.18%	-27.69%	-51.25%	67.36%	-25.55%	-37.30%
^NIFTY500 Nifty 500	-15.46%	1.60%	12.00%	25.12%	-6.42%	26.44%	14.14%	4.96%	-11.46%	44.69%

Different Trading Currencies

ADMA is traded in USD, while ^NIFTY500 is traded in INR. To make them comparable, the ^NIFTY500 values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, ADMA achieves a -50.05% return, which is significantly lower than ^NIFTY500's -15.46% return. Over the past 10 years, ADMA has underperformed ^NIFTY500 with an annualized return of 0.79%, while ^NIFTY500 has yielded a comparatively higher 8.75% annualized return.

ADMA

• 1D: 1.11%
• 1M: -45.05%
• YTD: -50.05%
• 6M: -39.47%
• 1Y: -53.09%
• 3Y*: 40.14%
• 5Y*: 37.85%
• 10Y*: 0.79%

^NIFTY500

• 1D: 3.15%
• 1M: -9.95%
• YTD: -15.46%
• 6M: -13.14%
• 1Y: -8.78%
• 3Y*: 8.22%
• 5Y*: 5.69%
• 10Y*: 8.75%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ADMA vs. ^NIFTY500 — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA

ADMA Risk / Return Rank: 7
ADMA Sharpe Ratio Rank: 5
ADMA Sortino Ratio Rank: 7
ADMA Omega Ratio Rank: 8
ADMA Calmar Ratio Rank: 11
ADMA Martin Ratio Rank: 3

^NIFTY500

^NIFTY500 Risk / Return Rank: 10
^NIFTY500 Sharpe Ratio Rank: 12
^NIFTY500 Sortino Ratio Rank: 12
^NIFTY500 Omega Ratio Rank: 12
^NIFTY500 Calmar Ratio Rank: 9
^NIFTY500 Martin Ratio Rank: 7

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADMA vs. ^NIFTY500 - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Nifty 500 (^NIFTY500). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ADMA	^NIFTY500	Difference
Sharpe ratio Return per unit of total volatility	-0.93	-0.54	-0.39
Sortino ratio Return per unit of downside risk	-1.32	-0.66	-0.66
Omega ratio Gain probability vs. loss probability	0.83	0.92	-0.09
Calmar ratio Return relative to maximum drawdown	-0.82	-0.51	-0.31
Martin ratio Return relative to average drawdown	-1.80	-1.72	-0.08
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ADMA vs. ^NIFTY500 - Sharpe Ratio Comparison

The current ADMA Sharpe Ratio is -0.93, which is lower than the ^NIFTY500 Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of ADMA and ^NIFTY500, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ADMA	^NIFTY500	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.93	-0.54	-0.39
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.63	0.37	+0.27
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.01	0.49	-0.48
Sharpe Ratio (All Time) Calculated using the full available price history	0.01	0.25	-0.24

Correlation

The correlation between ADMA and ^NIFTY500 is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Drawdowns

ADMA vs. ^NIFTY500 - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, which is greater than ^NIFTY500's maximum drawdown of -72.89%. Use the drawdown chart below to compare losses from any high point for ADMA and ^NIFTY500.

Drawdown Indicators

	ADMA	^NIFTY500	Difference
Max Drawdown Largest peak-to-trough decline	-91.28%	-68.02%	-23.26%
Max Drawdown (1Y) Largest decline over 1 year	-66.18%	-14.82%	-51.36%
Max Drawdown (5Y) Largest decline over 5 years	-66.18%	-18.84%	-47.34%
Max Drawdown (10Y) Largest decline over 10 years	-87.33%	-38.30%	-49.03%
Current Drawdown Current decline from peak	-62.83%	-14.54%	-48.29%
Average Drawdown Average peak-to-trough decline	-52.92%	-21.66%	-31.26%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.12%	3.62%	+26.50%

Volatility

ADMA vs. ^NIFTY500 - Volatility Comparison

ADMA Biologics, Inc. (ADMA) has a higher volatility of 32.15% compared to Nifty 500 (^NIFTY500) at 8.25%. This indicates that ADMA's price experiences larger fluctuations and is considered to be riskier than ^NIFTY500 based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ADMA	^NIFTY500	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.15%	8.25%	+23.90%
Volatility (6M) Calculated over the trailing 6-month period	44.57%	11.89%	+32.68%
Volatility (1Y) Calculated over the trailing 1-year period	57.46%	16.57%	+40.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.98%	15.77%	+44.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	69.11%	18.05%	+51.06%